WANG JUNYUAN JERRY (CEO, ANHEART THERAPEUTICS LTD.) reported 2 transactions at NUVATION BIO INC.
Review the transaction codes below to understand the nature of each event.
Class A Common Stock
Shares
+2.54M
Price / share
—
Trade value
—
% of position
Class A Common Stock
Shares
+1.70M
Price / share
—
Trade value
—
% of position
Net shares
+4.24M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 9/4/2024 | C · Conversion | +2.54M | — | — | 184.5% | 1.38M | 3.92M |
| Class A Common Stock Indirect | 9/4/2024 | C · Conversion | +1.70M | — | — | 307.9% | 550.76K | 2.25M |
| Total | +4.24M | $0.00 | ||||||
Series A Preferred Stock
Class A Common Stock
2.54M shares
Shares
+25.44K
Strike price
Held after
25.44K
Exercisable
—
Series A Preferred Stock
Class A Common Stock
1.70M shares
Shares
+16.96K
Strike price
Held after
16.96K
Exercisable
—
Warrants (Right to Buy)
Class A Common Stock
86.47K shares
Shares
+86.47K
Strike price
11.50
Held after
86.47K
Exercisable
—
Warrants (Right to Buy)
Class A Common Stock
57.65K shares
Shares
+57.65K
Strike price
11.50
Held after
57.65K
Exercisable
—
Series A Preferred Stock
Class A Common Stock
2.54M shares
Shares
−25.44K
Strike price
Held after
0.00
Exercisable
—
Series A Preferred Stock
Class A Common Stock
1.70M shares
Shares
−16.96K
Strike price
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Preferred Stock Direct | Class A Common Stock2.54M shares | 9/3/2024 | A · Award | +25.44K | — | 25.44K | |
| Series A Preferred Stock Indirect | Class A Common Stock1.70M shares | 9/3/2024 | A · Award | +16.96K | — | 16.96K | |
| Warrants (Right to Buy) Direct | Class A Common Stock86.47K shares | 9/3/2024 | A · Award | +86.47K | 11.50 | — | 86.47K |
| Warrants (Right to Buy) Indirect | Class A Common Stock57.65K shares | 9/3/2024 | A · Award | +57.65K | 11.50 | — | 57.65K |
| Series A Preferred Stock Direct | Class A Common Stock2.54M shares | 9/4/2024 | C · Conversion | −25.44K | — | 0.00 | |
| Series A Preferred Stock Indirect | Class A Common Stock1.70M shares | 9/4/2024 | C · Conversion | −16.96K | — | 0.00 |